CombiDiag: Peripheral Biomarker Based Combinatorial Early Diagnostics for Dementia
Marie Skłodowska-Curie grant agreement no. 101071485
CombiDiag (2023–2026) is a Marie Skłodowska-Curie Doctoral Network funded by the European Union under the Horizon Europe programme.
The mission of CombiDiag is to develop an AI-based diagnostic protocol for early-stage Alzheimer’s disease using peripheral biomarkers.
Meet the CombiDiag Team
Beneficiary Partners
Associated Partners
